WO2024241258 - ORAL PHARMACEUTICAL COMPOSITION OF ISAVUCONAZONIUM OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
National phase entry:
Publication Number
WO/2024/241258
Publication Date
28.11.2024
International Application No.
PCT/IB2024/055014
International Filing Date
23.05.2024
Title **
[English]
ORAL PHARMACEUTICAL COMPOSITION OF ISAVUCONAZONIUM OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
[French]
COMPOSITION PHARMACEUTIQUE ORALE D'ISAVUCONAZONIUM OU DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLES
Applicants **
BIOPHORE INDIA PHARMACEUTICALS PVT. LTD
Plot#92; 1-98/2/92, Kavuri Hills – Phase II, Jubilee Hills, Telangana.
Hyderabad 500033, IN
Inventors
PULLAGURLA, Manik Reddy
Plot#92; 1-98/2/92, Kavuri Hills – Phase II, Jubilee Hills, Telangana.
Hyderabad 500033, IN
ARUTLA, Srinivas
Plot#92; 1-98/2/92, Kavuri Hills – Phase II, Jubilee Hills, Telangana.
Hyderabad 500033, IN
TALASILA, Praveen Kumar
Plot#92; 1-98/2/92, Kavuri Hills – Phase II, Jubilee Hills, Telangana
Hyderabad 500033, IN
RANGISETTY, Jagadeesh Babu
Plot#92; 1-98/2/92, Kavuri Hills – Phase II, Jubilee Hills, Telangana
Hyderabad 500033, IN
Priority Data
202341035913
24.05.2023
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
IP India
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 961 | |
| EPO | Filing, Examination | 6349 | |
| Japan | Filing | 587 | |
| South Korea | Filing | 574 | |
| USA | Filing, Examination | 2710 |
Total: 11181 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present invention relates to an oral pharmaceutical composition of isavuconazonium or its pharmaceutically acceptable salts thereof. The present invention also relates to a process for preparing an oral pharmaceutical composition of isavuconazonium or its pharmaceutically acceptable salts thereof. It further relates to use of such compositions for the treatment of invasive aspergillosis or invasive Mucormycosis.[French]
La présente invention concerne une composition pharmaceutique orale d'isavuconazonium ou de ses sels pharmaceutiquement acceptables. La présente invention concerne également un procédé de préparation d'une composition pharmaceutique orale d'isavuconazonium ou de ses sels pharmaceutiquement acceptables. L'invention concerne en outre l'utilisation de telles compositions pour le traitement de l'aspergillose invasive ou de la mucormycose invasive.